CareDx 'applauds' progress in Medicare immunosuppressive medication legislation
CareDx said it, "applauds progress towards guaranteeing lifelong Medicare coverage of immunosuppressive medications for kidney transplant recipients.Recent conversations with legislative champions' offices indicate that the reintroduction of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act is imminent and expected this summer. The legislation would extend Medicare coverage for kidney transplant patients for the lifetime of the transplanted kidney" CareDx CEO Peter Maag presented at the American Association of Kidney Patients Policy Summit in Washington, D.C. on June 19, 2019. In a presentation to community leaders and kidney patients, he shared that "CareDx remains dedicated to improving the long-term health outcomes of transplant patients and a key component of that is ensuring patients have access to immunosuppressive medications for the life of their transplanted kidney. Medicare's current policy is costing the US health system and tax payers millions of dollars each year and even worse, costing patients their lives. The time for a legislative fix is long overdue and we're happy to work with the community to finally make it happen." CareDx has been working with other members of the kidney and transplant community, including AAKP, the National Kidney Foundation, the American Society of Nephrology, and Renal Physicians Associates, among many others, to urge Congress to pass legislation that would end Medicare's current three-year cap on immunosuppressive medications.